Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

NETS - Phase II Clinical Trials (Safety, POCC, Dose)

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon
Del.icio.us icon
Digg icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What are Phase II clinical trials and why are they important in drug development?

Phase II clinical trials are studies to evaluate the effectiveness of an investigational drug or therapy and observe short-term side effects and risks. They continue the study of drug safety and dose, and they also aim to provide proof of clinical concept (POCC) - that is, proof that the drug has the desired effect on individuals with a specific condition. This means that, unlike Phase I trials, Phase II trials include participants affected by the disease or condition of interest as opposed to the unaffected volunteers utilized in Phase I. Phase II clinical trials usually last around two years.

Testimonials: How we did it

Content not yet available for this section.

Relevant Publications

Content not yet available for this section.

 

Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.